Sermorelin 5 mg by Dragon Pharma is a synthetic analog of growth hormone–releasing hormone (GHRH), developed to explore natural stimulation of endogenous growth hormone (GH) secretion in research settings. It comprises the first 29 amino acids of the full GHRH sequence—recognized as the active core—making it highly effective in triggering GH release from the anterior pituitary in test environments.
Mechanism of Action
Sermorelin binds to GHRH receptors on pituitary cells, initiating a cascade that leads to increased secretion of growth hormone (GH). This action indirectly promotes the production of insulin-like growth factor-1 (IGF-1), a critical molecule involved in tissue repair, muscle development, metabolism, and cellular regeneration.
Unlike direct GH analogs, Sermorelin operates through the body's natural feedback mechanisms, which may allow for a more balanced hormone profile and reduced risk of suppression. Studies show it may enhance sleep quality, accelerate recovery, and support age-related hormonal decline in animal models.
Key Features & Benefits
- Endogenous GH Release: Stimulates the body's own production of growth hormone via the GHRH pathway.
- Supports Muscle Growth: Indirectly promotes lean tissue development and recovery through IGF-1 upregulation.
- Age-Related Research: Studied for its potential to offset age-associated decline in GH levels and energy.
- Neuroendocrine Balance: Works with natural biological rhythms to encourage hormone balance without overstimulation.
- Regenerative Effects: Linked to improved skin tone, immune modulation, and metabolic support in preclinical studies.
Legal Disclaimer
Disclaimer: This product is for laboratory and scientific research only. It is not approved for medical, therapeutic, or human use. Handle with appropriate laboratory safety procedures.
Frequently Asked Questions
Sermorelin is a synthetic peptide that mimics the function of GHRH to stimulate natural growth hormone secretion in research subjects.
It is studied for its potential in promoting muscle growth, improving metabolic health, and addressing hormonal decline associated with aging.
While Sermorelin primarily stimulates GH, increased IGF-1 levels may indirectly support hormonal balance, including testosterone levels, in research models.
In laboratory settings, Sermorelin is typically administered via subcutaneous injection near the abdominal area, depending on the study protocol.
